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TUMOR NECROSIS FACTOR ALPHA TRIGGERS OSTEOGENESIS 
THROUGH THE INVOVLVEMENT OF Gs-COUPLED RECEPTOR 
SIGNALS
Tumor Necrosis Factor alpha (TNF-a) plays a role in  several chronic immune and inflammatory 
diseases,  where  inhibition  of  TNF has  led  to  significant  clinical  improvement.  Actually,  this 
cytokine is involved in bone healing by affecting mesenchymal stem cell (MSC) behaviour in a 
dose- and time-dependent manner1,2. Indeed, in the early inflammatory phase after fracture, low 
doses of TNF-a are required to favour MSC migration, survival and differentiation, thus initiating 
bone repair. At high dose, in the chronic uncontrolled phase of inflammation, the same cytokine 
has destructive effects on bone and contribute to bone loss1,2. 
As other soluble factors released in cell microenvironment, the cytokine modulates expression and 
functioning of different  G protein coupled receptors  (GPCRs) and of their  regulatory proteins 
(GPCR regulated kinases, GRKs)3, thus dictating the final biological outcome of these receptor 
proteins in controlling bone anabolic processes. 
Herein,  we  investigated  the  effects  of  TNF-a low  doses  on  the  expression  and  functional 
responsiveness  of  A2B adenosine  receptor  (A2B AR),  a  Gs-coupled  puringergic  receptor  that 
controls mesenchymal stem cell (MSC) differentiation to osteoblasts4,5.
In our hands, TNF-a exerted a pro-differentiating action on MSCs, pushing towards an osteoblast 
phenotype,  and without any effects  on cell  proliferation.   The cytokine increased the  A2B AR-
mediated  pro-osteogenic  effects,  through the  A2B AR  desensitization  impairment  mediated  by 
GRK2 inhibition. These data i) support the anabolic effect of sub-massimal concentration of TNF-
a in bone reparative processes and ii) demonstrate that the cytokine regulates GPCR responses by 
interfering with desensitization machinery and potentiating in turn the anabolic responses evoked 
by  Gs-GPCRs.  Overall  these  results  indicated  that  manipulating  MSC local  environment  by 
lregulates membrane receptors favouring bone remodelling.
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